{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T02:45:41Z","timestamp":1783997141006,"version":"3.55.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T00:00:00Z","timestamp":1751673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T00:00:00Z","timestamp":1751673600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-025-04953-9","type":"journal-article","created":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T12:12:37Z","timestamp":1751717557000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Incidence, predictors, and prognostic impact of reperfusion-related ventricular arrhythmias in STEMI patients undergoing primary percutaneous coronary intervention"],"prefix":"10.1186","volume":"25","author":[{"given":"Xi","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haobo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,5]]},"reference":[{"issue":"10","key":"4953_CR1","doi-asserted-by":"publisher","first-page":"16812","DOI":"10.1002\/jcp.28350","volume":"234","author":"AK Malakar","year":"2019","unstructured":"Malakar AK, Choudhury D, Halder B, Paul P, Uddin A, Chakraborty S. A review on coronary artery disease, its risk factors, and therapeutics. J Cell Physiol. 2019;234(10):16812\u201323.","journal-title":"J Cell Physiol"},{"issue":"2","key":"4953_CR2","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"B Ibanez","year":"2018","unstructured":"Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European society of cardiology (ESC). Eur Heart J. 2018;39(2):119\u201377.","journal-title":"Eur Heart J"},{"issue":"11","key":"4953_CR3","first-page":"774","volume":"38","author":"G Heusch","year":"2017","unstructured":"Heusch G, Gersh BJ. The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge. Eur Heart J. 2017;38(11):774\u201384.","journal-title":"Eur Heart J"},{"issue":"3","key":"4953_CR4","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1378\/chest.126.3.702","volume":"126","author":"M Kato","year":"2004","unstructured":"Kato M, Dote K, Sasaki S, Takemoto H, Habara S, Hasegawa D. Intracoronary verapamil rapidly terminates reperfusion tachyarrhythmias in acute myocardial infarction. Chest. 2004;126(3):702\u20138.","journal-title":"Chest"},{"issue":"1","key":"4953_CR5","doi-asserted-by":"publisher","first-page":"83","DOI":"10.59249\/LSWK8578","volume":"96","author":"J Frampton","year":"2023","unstructured":"Frampton J, Ortengren AR, Zeitler EP. Arrhythmias after acute myocardial infarction. Yale J Biol Med. 2023;96(1):83\u201394.","journal-title":"Yale J Biol Med"},{"key":"4953_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1146\/annurev-physiol-021014-071622","volume":"77","author":"Z Qu","year":"2015","unstructured":"Qu Z, Weiss JN. Mechanisms of ventricular arrhythmias: from molecular fluctuations to electrical turbulence. Annu Rev Physiol. 2015;77:29\u201355.","journal-title":"Annu Rev Physiol"},{"issue":"10","key":"4953_CR7","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1016\/j.jacc.2003.09.072","volume":"43","author":"RH Mehta","year":"2004","unstructured":"Mehta RH, Harjai KJ, Grines L, Stone GW, Boura J, Cox D, et al. Sustained ventricular tachycardia or fibrillation in the cardiac catheterization laboratory among patients receiving primary percutaneous coronary intervention: incidence, predictors, and outcomes. J Am Coll Cardiol. 2004;43(10):1765\u201372.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"4953_CR8","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1253\/circj.CJ-16-0183","volume":"80","author":"M Masuda","year":"2016","unstructured":"Masuda M, Nakatani D, Hikoso S, Suna S, Usami M, Matsumoto S, et al. Clinical impact of ventricular tachycardia and\/or fibrillation during the acute phase of acute myocardial infarction on In-Hospital and 5-Year mortality rates in the percutaneous coronary intervention era. Circulation Journal: Official J Japanese Circulation Soc. 2016;80(7):1539\u201347.","journal-title":"Circulation Journal: Official J Japanese Circulation Soc"},{"issue":"7","key":"4953_CR9","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.amjcard.2017.12.036","volume":"121","author":"T Podolecki","year":"2018","unstructured":"Podolecki T, Lenarczyk R, Kowalczyk J, Jedrzejczyk-Patej E, Chodor P, Mazurek M, et al. Prognostic significance of complex ventricular arrhythmias complicating ST-Segment elevation myocardial infarction. Am J Cardiol. 2018;121(7):805\u20139.","journal-title":"Am J Cardiol"},{"issue":"1","key":"4953_CR10","first-page":"30","volume":"73","author":"H Taha","year":"2021","unstructured":"Taha H, Shaker MM. Percutaneous management of reperfusion arrhythmias during primary percutaneous coronary intervention: a case report. Egypt Heart Journal: (EHJ): Official Bull Egypt Soc Cardiol. 2021;73(1):30.","journal-title":"Egypt Heart Journal: (EHJ): Official Bull Egypt Soc Cardiol"},{"issue":"22","key":"4953_CR11","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1016\/j.jacc.2007.09.011","volume":"50","author":"K Thygesen","year":"2007","unstructured":"Thygesen K, Alpert JS, White HD. Universal definition of myocardial infarction. J Am Coll Cardiol. 2007;50(22):2173\u201395.","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"4953_CR12","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.1007\/s00330-009-1489-0","volume":"19","author":"SC Bekkers","year":"2009","unstructured":"Bekkers SC, Backes WH, Kim RJ, Snoep G, Gorgels AP, Passos VL, et al. Detection and characteristics of microvascular obstruction in reperfused acute myocardial infarction using an optimized protocol for contrast-enhanced cardiovascular magnetic resonance imaging. Eur Radiol. 2009;19(12):2904\u201312.","journal-title":"Eur Radiol"},{"issue":"4","key":"4953_CR13","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1007\/s12350-019-01903-9","volume":"28","author":"H Patel","year":"2021","unstructured":"Patel H, Doppalapudi H, Hage FG. Myocardial infarction assessment by surface electrocardiography. J Nuclear Cardiology: Official Publication Am Soc Nuclear Cardiol. 2021;28(4):1374\u20137.","journal-title":"J Nuclear Cardiology: Official Publication Am Soc Nuclear Cardiol"},{"issue":"12","key":"4953_CR14","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1007\/s11886-023-02001-6","volume":"25","author":"C O\u2019Donnell","year":"2023","unstructured":"O\u2019Donnell C, Sanchez PA, Celestin B, McConnell MV, Haddad F. The echocardiographic evaluation of the right heart: current and future advances. Curr Cardiol Rep. 2023;25(12):1883\u201396.","journal-title":"Curr Cardiol Rep"},{"issue":"23","key":"4953_CR15","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1093\/eurheartj\/ehn416","volume":"29","author":"F Van de Werf","year":"2008","unstructured":"Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the task force on the management of ST-Segment elevation acute myocardial infarction of the European society of cardiology. Eur Heart J. 2008;29(23):2909\u201345.","journal-title":"Eur Heart J"},{"issue":"17","key":"4953_CR16","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","volume":"115","author":"DE Cutlip","year":"2007","unstructured":"Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007;115(17):2344\u201351.","journal-title":"Circulation"},{"issue":"2","key":"4953_CR17","first-page":"122","volume":"18","author":"H Khederlou","year":"2023","unstructured":"Khederlou H, Azimi Pirsaraei SV, Rabbani E, Motedayen M. Correlations between cardiovascular risk factors and ventricular arrhythmias following primary percutaneous coronary intervention in patients with ST-Elevation myocardial infarction. J Tehran Heart Cent. 2023;18(2):122\u20138.","journal-title":"J Tehran Heart Cent"},{"issue":"12","key":"4953_CR18","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1016\/j.amjcard.2009.07.037","volume":"104","author":"CJ Terkelsen","year":"2009","unstructured":"Terkelsen CJ, S\u00f8rensen JT, Kaltoft AK, Nielsen SS, Thuesen L, B\u00f8tker HE, et al. Prevalence and significance of accelerated idioventricular rhythm in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention. Am J Cardiol. 2009;104(12):1641\u20136.","journal-title":"Am J Cardiol"},{"issue":"1","key":"4953_CR19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1253\/circrep.CR-19-0081","volume":"2","author":"J Oikawa","year":"2019","unstructured":"Oikawa J, Fukaya H, Ako J, Nakao K, Ozaki Y, Kimura K, et al. Risk factors of In-Hospital lethal arrhythmia following acute myocardial infarction in patients undergoing primary percutaneous coronary Intervention\u3000- insight from the J-MINUET study. Circulation Rep. 2019;2(1):17\u201323.","journal-title":"Circulation Rep"},{"issue":"1","key":"4953_CR20","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1159\/000047382","volume":"96","author":"JA Chiladakis","year":"2001","unstructured":"Chiladakis JA, Pashalis A, Patsouras N, Manolis AS. Autonomic patterns preceding and following accelerated idioventricular rhythm in acute myocardial infarction. Cardiology. 2001;96(1):24\u201331.","journal-title":"Cardiology"},{"issue":"12","key":"4953_CR21","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1056\/NEJM199103213241201","volume":"324","author":"DS Echt","year":"1991","unstructured":"Echt DS, Liebson PR, Mitchell LB, Peters RW, Obias-Manno D, Barker AH, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The cardiac arrhythmia suppression trial. N Engl J Med. 1991;324(12):781\u20138.","journal-title":"N Engl J Med"},{"issue":"2","key":"4953_CR22","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1161\/01.CIR.87.2.312","volume":"87","author":"AP Maggioni","year":"1993","unstructured":"Maggioni AP, Zuanetti G, Franzosi MG, Rovelli F, Santoro E, Staszewsky L, et al. Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era. GISSI-2 results. Circulation. 1993;87(2):312\u201322.","journal-title":"Circulation"},{"key":"4953_CR23","doi-asserted-by":"crossref","unstructured":"Badura K, Bu\u0142awska D, D\u0105bek B, Witkowska A, Lisi\u0144ska W, Radzioch E et al. Primary electrical heart Disease-Principles of pathophysiology and genetics. Int J Mol Sci. 2024;25(3):1826.","DOI":"10.3390\/ijms25031826"},{"issue":"1","key":"4953_CR24","first-page":"e13016","volume":"28","author":"P Zhou","year":"2023","unstructured":"Zhou P, Wu Y, Wang M, Zhao Y, Yu Y, Waresi M, et al. Identifying the culprit artery via 12-lead electrocardiogram in inferior wall ST-segment elevation myocardial infarction: A meta-analysis. Annals of noninvasive electrocardiology: the official journal of the international society for Holter and noninvasive electrocardiology. Inc. 2023;28(1):e13016.","journal-title":"Inc"},{"issue":"17","key":"4953_CR25","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1001\/jama.2009.600","volume":"301","author":"RH Mehta","year":"2009","unstructured":"Mehta RH, Starr AZ, Lopes RD, Hochman JS, Widimsky P, Pieper KS, et al. Incidence of and outcomes associated with ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention. JAMA. 2009;301(17):1779\u201389.","journal-title":"JAMA"},{"issue":"2","key":"4953_CR26","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.cct.2010.12.013","volume":"32","author":"KW Mahaffey","year":"2011","unstructured":"Mahaffey KW, Wampole JL, Stebbins A, Berdan LG, McAfee D, Rorick TL, et al. Strategic lessons from the clinical event classification process for the assessment of Pexelizumab in acute myocardial infarction (APEX-AMI) trial. Contemp Clin Trials. 2011;32(2):178\u201387.","journal-title":"Contemp Clin Trials"},{"key":"4953_CR27","doi-asserted-by":"publisher","first-page":"160380","DOI":"10.1155\/2013\/160380","volume":"2013","author":"E Tatli","year":"2013","unstructured":"Tatli E, Alicik G, Buturak A, Yilmaztepe M, Aktoz M. Arrhythmias following revascularization procedures in the course of acute myocardial infarction: are they indicators of reperfusion or ongoing ischemia? Sci World J. 2013;2013:160380.","journal-title":"Sci World J"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-04953-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-025-04953-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-04953-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T12:12:38Z","timestamp":1751717558000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-025-04953-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,5]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4953"],"URL":"https:\/\/doi.org\/10.1186\/s12872-025-04953-9","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,5]]},"assertion":[{"value":"30 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present research was carried out in accordance with the tenets mentioned in the Helsinki Declaration and was approved by the Ethical Board of Xiangtan Central Hospital (approval number: X2018083662-1). Prior to the commencement of the research, our team obtained written informed consent from each patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. No individual patient data will be reported.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"494"}}